Psilocybin Trials For COVID-Related Distress Of Healthcare Professionals Could Validate New Psychotherapy Model

ByQuantisnow·Wall Street's wire, on your screen.

Stocks in this Quantisnow insightHealth Care

CYBNAMEXCybin Inc.
Alert me

Quantisnow market dataAMEX

CYBN

Cybin Inc.

Market cap
30-day
Sector: Health Care
Industry: Biotechnology: Pharmaceutical Preparations

Get push alerts for CYBN

Follow CYBN and get a push notification the moment its next story breaks.

Full CYBN profile on Quantisnow

Delivered by Quantisnow

Get the next CYBN story the moment it breaks

Quantisnow reads SEC filings, FDA decisions, analyst ratings, insider trades and press releases straight off the wire and alerts you on the tickers you follow, so you read it before the market prices it in.

Push to your phoneQuantisnow app for iOS and Android
Email alertHeadline, tickers and the source link
Live feedStreams in as the wire publishes

Quantisnow Free vs Plus
Feature	Free	Plus
Delivery	On a delay	Real time, ~350ms
Followed tickers	Up to 5	Up to 250
Push + email alerts	Daily limit	Every story
Price	$0	$69/mo

Continue with Google Sign up with email Free to start. Plus is $69/mo